What is NDC 58160-894?

58160-894 is the product NDC for Arexvy kit, listed with the FDA by GlaxoSmithKline Biologicals SA. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Arexvy (Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted).

GlaxoSmithKline Biologicals SA, NDC labeler code 58160. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Arexvy?

2 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Arexvy NDC 58160-894 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)58160-894Labeler and product segments. Claims need a package NDC.

Product NDC at billing width58160-0894Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
58160-894-15	5816008941558160089415	1 KIT in 1 CARTON (58160-894-15) * .5 mL in 1 VIAL (58160-719-03) * .5 mL in 1 SYRINGE (58160-749-07)Marketed from Apr 30, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Arexvy
Generic name (nonproprietary): respiratory syncytial virus vaccine recombinant, adjuvanted
Dosage form: Kit
Labeler: GlaxoSmithKline Biologicals SANDC labeler code 58160
Product type: Vaccine
Marketing category: BLA — Biologics License ApplicationApplication BLA 125775
Marketing start: Apr 30, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 58160-894_ed295307-eb7c-42c3-80a2-080a316c8954SPL ID ed295307-eb7c-42c3-80a2-080a316c8954

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Immunization administration (CPT 90460–90474)

Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.

How CPT relates to drug billing

NDC on a medical claim

N458160089415 followed by a unit qualifier and the quantity

Package 58160-0894-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 58160-894

What is NDC 58160-894?: 58160-894 is the product NDC for Arexvy kit, listed with the FDA by GlaxoSmithKline Biologicals SA. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Arexvy (Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted).
Who is the labeler?: GlaxoSmithKline Biologicals SA, NDC labeler code 58160. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Arexvy?: 2 other product NDCs are listed under this name. See all Arexvy NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Arexvy NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Arexvyrespiratory syncytial virus vaccine recombinant, adjuvanted	—	Kit	GlaxoSmithKline Biologicals SA	58160-882	58160-0882-12
Arexvyrespiratory syncytial virus vaccine recombinant, adjuvanted	—	Kit	GlaxoSmithKline Biologicals SA	58160-848	58160-0848-11

Other NDCs under BLA 125775

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 125775
Product	Strength	Form · route	Labeler	Product NDC
Arexvyrespiratory syncytial virus vaccine recombinant, adjuvanted	—	Kit	GlaxoSmithKline Biologicals SA	58160-848
Arexvyrespiratory syncytial virus vaccine recombinant, adjuvanted	—	Kit	GlaxoSmithKline Biologicals SA	58160-882